NovoCure Limited (NVCR) Capital expenditures 2017–2026
NovoCure Limited (NVCR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$26.6MFY2026 · since FY2017: $5.7M → $26.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $26.6M | -37.8% |
| FY2025 | $42.9M | +58.2% |
| FY2024 | $27.1M | +26.9% |
| FY2023 | $21.4M | -11.6% |
| FY2022 | $24.2M | +61.5% |
| FY2021 | $15.0M | +42.8% |
| FY2020 | $10.5M | +56.2% |
| FY2019 | $6.7M | -8.9% |
| FY2018 | $7.4M | +29.8% |
| FY2017 | $5.7M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice